Guideline on the Treatment of Basal Cell Carcinoma
نویسندگان
چکیده
Members of EDF Guideline Committee: Prof. Dr. Werner Aberer, Graz (Austria) Prof. Dr. Dieter Metze, Muenster (Germany) Prof. Dr. Martine Bagot, Paris (France) Prof. Dr. Gillian Murphy, Dublin (Ireland) Prof. Dr. Nicole Basset-Seguin, Paris (France) PD Dr. Alexander Nast, Berlin (Germany) Prof. Dr. Ulrike Blume-Peytavi, Berlin (Germany) Prof. Dr. Martino Neumann, Rotterdam (Netherlands) Prof. Dr. Lasse Braathen, Bern (Switzerland) Prof. Dr. Tony Ormerod, Aberdeen (United Kingdom) Prof. Dr. Sergio Chimenti, Rome (Italy) Prof. Dr. Mauro Picardo, Rome (Italy) Prof. Dr. Alexander Enk, Heidelberg (Germany) Prof. Dr. Annamari Ranki, Helsinki (Finland) Prof. Dr. Claudio Feliciani, Rome (Italy) Prof. Dr. Johannes Ring, Munich (Germany) Prof. Dr. Claus Garbe, Tuebingen (Germany) Prof. Dr. Berthold Rzany, Berlin (Germany) Prof. Dr. Harald Gollnick, Magdeburg (Germany) Prof. Dr. Rudolf Stadler, Minden (Germany) Prof. Dr. Gerd Gross, Rostock (Germany) Prof. Dr. Sonja Ständer, Muenster (Germany) Prof. Dr. Vladimir Hegyi, Bratislava (Slovakia) Prof. Dr. Wolfram Sterry, Berlin (Germany) Prof. Dr. Michael Hertl, Marburg (Germany) Prof. Dr. Eggert Stockfleth, Bochum (Germany) Prof. Dr. Dimitrios Ioannides, Thessaloniki (Greece) Prof. Dr. Alain Taieb, Bordeaux (France) Prof. Dr. Gregor Jemec, Roskilde (Denmark) Prof. Dr. George-Sorin Tiplica, Bucharest (Romania) Prof. Dr. Lajos Kemény, Szeged (Hungary) Prof. Dr. Nikolai Tsankov, Sofia (Bulgaria) Dr. med. habil. Gudula Kirtschig, Nottingham (United Kingdom); Tübingen (Germany) Prof. Dr. Elke Weisshaar, Heidelberg (Germany) Prof. Dr. Robert Knobler, Vienna (Austria) Prof. Dr. Sean Whittaker, London (United Kingdom) Prof. Dr. Annegret Kuhn, Muenster (Germany) Prof. Dr. Fenella Wojnarowska, Oxford (United Kingdom) Prof. Dr. Marcus Maurer, Berlin (Germany) Prof. Dr. Christos Zouboulis, Dessau (Germany) Prof. Dr. Kai Munte, Rotterdam (Netherlands) Prof. Dr. Torsten Zuberbier, Berlin (Germany)
منابع مشابه
Comparison of COX2 expression in radiation induced basal cell carcinoma and non-radiation induced basal cell carcinoma
Background: Radiation-induced basal cell carcinoma (BCC) can be multiple, large, and recurring, which complicates its treatment in some cases. According to reports on the role of cyclooxygenase 2 (COX2) inhibitors in the treatment or prevention of non-melanoma skin cancers and considering the fact that COX2 expression has not been evaluated in radiation-in...
متن کاملAnatomical location of basal cell carcinoma in relation to histopathological subtypes: Analysis of 189 cases in Hamadan Sina Hospital during 1997-99
Background: Basal cell carcinoma (BCC) is the most common skin cancer in whites. Objective: Determination of anatomical localization of BCC in relation to histological subtypes of this tumor. Patients and methods: This survey is a descriptive cross sectional study carried out on 189 cases of BCC patients diagnosed in Hamadan Sina hospital between 1997-1999. Results: This study showed 7 hi...
متن کاملBasal cell carcinoma superimposed on an old scar of localized cutaneous Leishmaniasis: A case report
Basal cell carcinoma (BCC) is the most common malignant tumor of the skin, which originates from the basal cell layer of the skin. It is more common in white race with skin types I and II. Some predisposing factors are sunlight, ionizing radiation, arsenic salts, PUVA and scar. We present a case of BCC, which appeared over an old scar of localized cutaneous leishmaniasis in a 49-year-old woman.
متن کاملEvaluation of the Primary Response of Basal Cell Carcinoma to Aminolevulinic Acid Photodynamic Therapy
Background: Basal Cell Carcinoma (BCC) is the most common type of skin cancer in human beings. Photodynamic therapy (PDT) is a novel therapeutic method which may be regarded as a non-invasive useful alternative for traditional treatments of BCC. This study was designed with the aim of evaluating the primary response of BCC to PDT.Methods: This clinical trial was perform...
متن کامل